Louis Reichardt

Director
SFARI

Louis Reichardt joined the foundation to lead SFARI in 2013. Prior to assuming this post, he was the Jack D. and DeLoris Lange endowed chair in cell physiology at the University of California, San Francisco, where he had directed its renowned neuroscience graduate program since 1988. A Fulbright scholar with an undergraduate degree from Harvard University and a Ph.D. from Stanford University, Reichardt was a research fellow at Harvard Medical School and a Howard Hughes investigator for more than 20 years.

The recipient of a Guggenheim fellowship in 1985, he is a fellow of both the American Association for the Advancement of Science and the American Academy of Arts and Sciences. He was one of three founding editors of the journal Neuron and is a senior editor of the Journal of Cell Biology. He serves on the editorial boards of several other journals as well as the scientific advisory boards of the Christopher and Dana Reeve Spinal Cord Injury and Paralysis Foundation and the Myelin Repair Foundation.

Reichardt’s research has focused on neurotrophins, a family of proteins that play a key role in neuron functioning, and on another family of proteins that promote the adhesion of nerve cells to each other. He has made major contributions to the study of intracellular signaling pathways that mediate the effects of these proteins ‰ÛÓ including the Wnt pathway, which may play a role in autism spectrum disorders.

From this contributor

Explore more from The Transmitter

Attention not necessary for visual awareness, large study suggests

People can perceive some visual information even if they do not pay direct attention to it.

By Kristel Tjandra
1 July 2025 | 5 min read
Research image of mouse brain slices.

Genetic testing; LSD1 inhibitors; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 30 June.

By Daisy Yuhas
1 July 2025 | 2 min read

INSAR takes ‘intentional break’ from annual summer webinar series

The International Society for Autism Research cited a need to “thoughtfully reimagine” its popular online program before resuming it in 2026.

By Lauren Schenkman
30 June 2025 | 4 min read